Skip to main content
Clinical Trials/NCT05520398
NCT05520398
Recruiting
Not Applicable

Cognitive and Neural Networks in Psychiatry (CNNP): Neural Mechanisms of Obsessive-compulsive Disorder (OCD) Treatment Failure (ERP in Silico)

University College, London1 site in 1 country90 target enrollmentNovember 10, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obsessive-Compulsive Disorder
Sponsor
University College, London
Enrollment
90
Locations
1
Primary Endpoint
Yale-Brown obsessive compulsive scale (Y-BOCS)
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The aim of this study is to understand why patients with obsessive-compulsive disorder (OCD) fail in therapy.

To understand the neural mechanisms involved in exposure therapy that support success and clinical improvement in order to improve therapy outcomes for OCD patients.

Detailed Description

A course of therapy is recommended for individuals with obsessive-compulsive disorder (OCD). It is usually a type of cognitive behavioural therapy (CBT) with exposure and response prevention (ERP). In this study the investigators assess patients pre-therapy and post-therapy evaluating symptom severity (measured by the Y-BOCS) and decision-making (measured by online questionnaires and computer-based behavioural tasks). To examine how decisions are formed in patients undergoing OCD CBT, how behaviour changes after a non-pharmacological therapy module and how it is associated to the alleviation of OCD symptoms. The study, which will recruit 90 patients, is based at University College London - Wellcome Centre for Human Neuroimaging. This study is a part of the Cognitive and Neural Networks in Psychiatry (CNNP) study.

Registry
clinicaltrials.gov
Start Date
November 10, 2021
End Date
December 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of obsessive-compulsive disorder (OCD)
  • Fluent in written and spoken English
  • Normal/corrected to normal vision
  • Expecting to start OCD therapy

Exclusion Criteria

  • Autism spectrum disorder, psychosis, schizophrenia, addiction, substance abuse, bipolar, hoarding, or Tourette disorder
  • Hearing conditions: tinnitus, ear inflammation, hearing sensitivity, hearing loss, requires hearing aids
  • Colour blindness
  • Severe learning disabilities

Outcomes

Primary Outcomes

Yale-Brown obsessive compulsive scale (Y-BOCS)

Time Frame: 3 - 9 months

The Y-BOCS is a 10-item scale used to assess symptom severity in OCD.

Decision making and learning tasks

Time Frame: 3 - 9 months

Computer-based behavioural task developed by the investigators to understand decision making in OCD.

Secondary Outcomes

  • Patient EX/RP Adherence Scale (PEAS)(3 - 9 months)
  • International Cognitive Ability Resource (ICAR16)(3 - 9 months)
  • The World Health Organization Quality of Life Brief Version (WHOQOL-BREF)(3 - 9 months)
  • Sheehan Disability Scale (SDS)(3 - 9 months)
  • Brief Experiential Avoidance Questionnaire (BEAQ)(3 - 9 months)
  • State-Trait Anxiety Inventory (STAI)(3 - 9 months)
  • Zung Self-Rating Depression Scale (SDS)(3 - 9 months)
  • Short form of Obsessive Beliefs Questionnaire (OBQ)(3 - 9 months)
  • Worry Domains Questionnaire - Short Form (WDQ-SF)(3 - 9 months)
  • Anxiety Sensitivity Index (ASI-3)(3 - 9 months)

Study Sites (1)

Loading locations...

Similar Trials